I
IMDX
Insight Molecular Diagnostics In…
3.170
-0.010-0.31%After Hours: 3.250 +0.080 +2.52%17:21 04/10 EDT
OPEN/PREV CLOSE3.210/3.180
TODAY RANGE2.645-3.225
VOL415.15K
MARKET CAP101.97M
52 WEEK RANGE2.330-8.51
AVG VOL (3M)141.74K
% TURNOVER1.29%
TURNOVER--
P/E (TTM)-1.9237
% RANGE17.77%
EPS(TTM)-1.6479
P/E(FORWARD)-3.6437
P/B-2.8897
BVPS-1.0970
DIVIDEND--
P/S22.42
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP81.30M
SHARES OUTSTANDING32.17M
NEXT EARNINGS05/11-05/15
FREE FLOAT25.65M
LOT SIZE1
EX-DATE07/25/2023
News
Press Releases
Financial Reports
Profile
Benzinga·1d ago
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·6d ago
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
Benzinga·03/31 17:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·03/31 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·03/30 17:05
12 Health Care Stocks Moving In Monday's Intraday Session
TipRanks·03/26 20:51
Insight Molecular Diagnostics submits GraftAssureDx for FDA review
TipRanks·03/26 20:45
Insight Molecular Diagnostics reports Q4 EPS (27c) vs. (28c) last year
Dow Jones·03/26 20:16
*Insight Molecular Diagn 4Q Rev $1.14M >IMDX
Dow Jones·03/26 20:16
*Insight Molecular Diagn 4Q Loss/Shr 72c >IMDX